Monofer (Ferric Derisomaltose)

Monofer is an intravenous iron preparation used to correct iron deficiency in several clinical settings.

• Iron deficiency anemia (IDA): restores hemoglobin levels and replenishes iron stores in patients with insufficient iron.
• Chronic kidney disease‑related anemia: provides intravenous iron to support erythropoiesis when oral iron is ineffective.
• Pre‑operative anemia: corrects iron deficiency before surgery to reduce the need for blood transfusion.

• Ferric derisomaltose forms a stable iron‑carbohydrate complex that is taken up by the reticuloendothelial system after intravenous infusion. The complex is processed within macrophages, releasing elemental iron that binds to transferrin and becomes available for incorporation into hemoglobin during erythropoiesis, thereby correcting iron deficiency.

Common Side Effects

• Nausea: mild to moderate feeling of stomach upset.
• Headache: transient headache occurring during or shortly after infusion.
• Injection site reactions: redness, swelling, or discomfort at the infusion site.
• Dizziness: temporary light‑headedness during administration.
• Mild hypotension: slight drop in blood pressure, usually self‑limiting.
• Flushing: brief warmth or reddening of the skin.

Serious or Rare Side Effects

• Anaphylaxis: severe allergic reaction requiring immediate medical attention.
• Severe hypotension: marked blood pressure drop that may need intervention.
• Hypersensitivity reactions: rash, bronchospasm, or angioedema.
• Iron overload: excessive iron accumulation with potential organ damage.
• Acute respiratory distress: difficulty breathing during or after infusion.

Monofer should be administered only after confirming iron deficiency and evaluating the patient’s overall clinical status.

• Assess iron status before administration: confirm diagnosis of iron deficiency anemia.
• Monitor for hypersensitivity: observe the patient during and after infusion for allergic reactions.
• Avoid rapid infusion rates: follow recommended infusion guidelines to reduce hypotension risk.
• Use with caution in patients with cardiac disease: monitor cardiovascular status closely.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Ferric derisomaltose may interact with other agents that affect iron metabolism or cardiovascular stability.

Major Interactions (Avoid)

• Concurrent use of other IV iron products: increases risk of iron overload.
• Co‑administration with erythropoiesis‑stimulating agents without iron monitoring: may exacerbate hypertension.
• High‑dose vitamin C: enhances free iron levels, raising oxidative stress risk.

Moderate Interactions (Monitor Closely)

• Oral iron supplements: can interfere with laboratory assessment of iron parameters.
• Antihypertensive drugs: monitor blood pressure as infusion may cause transient hypotension.